Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Lowered to Hold at Jefferies Financial Group

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) was downgraded by research analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, Briefing.com reports.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Performance

Shares of MURGY stock opened at $54.80 on Monday. The stock’s 50-day moving average is $53.26 and its two-hundred day moving average is $49.90. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.12 and a current ratio of 1.12. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1 year low of $39.08 and a 1 year high of $55.71. The firm has a market cap of $74.78 billion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.69 and a beta of 1.02.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. The firm had revenue of $16.10 billion for the quarter. Analysts predict that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 5.75 earnings per share for the current year.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.